These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 10550427)
1. Tolerance to kidney allograft transplanted into Type I diabetic patients persists after in vivo challenge with pancreatic islet allografts that express repeated mismatches. Stobbe I; Duinkerken G; van Rood JJ; Lernmark A; Keymeulen B; Pipeleers D; De Vries RR; Glass FH; Roep BO Diabetologia; 1999 Nov; 42(11):1379-80. PubMed ID: 10550427 [No Abstract] [Full Text] [Related]
2. Effect of pancreatic islet allografts on kidney allograft rejection incidence in simultaneous islet/kidney and islet after kidney recipients. Wahoff DC; Najarian JS; Sutherland DE; Gores PF Transplant Proc; 1994 Apr; 26(2):576. PubMed ID: 8171562 [No Abstract] [Full Text] [Related]
3. Alloreactivity against repeated HLA mismatches of sequential islet grafts transplanted in non-uremic type 1 diabetes patients. van Kampen CA; van de Linde P; Duinkerken G; van Schip JJ; Roelen DL; Keymeulen B; Pipeleers DG; Claas FH; Roep BO Transplantation; 2005 Jul; 80(1):118-26. PubMed ID: 16003242 [TBL] [Abstract][Full Text] [Related]
4. Failure of nonimmunogenic islet allografts to induce donor-specific immunological unresponsiveness [corrected]. Ketchum RJ; Moyer C; Su HC; Moore WV Cell Transplant; 1994; 3(2):179-86. PubMed ID: 8012733 [TBL] [Abstract][Full Text] [Related]
5. Effect of intraportal human islet transplantation on kidney graft survival in simultaneous kidney-islet allografts. Rilo HR; Carroll PB; Shapiro R; Fontes P; Scantlebury V; Irish W; Tzakis AG; Starzl TE; Ricordi C Transplant Proc; 1993 Feb; 25(1 Pt 2):955-6. PubMed ID: 7680172 [No Abstract] [Full Text] [Related]
6. CCL22 Prevents Rejection of Mouse Islet Allografts and Induces Donor-Specific Tolerance. Montane J; Obach M; Alvarez S; Bischoff L; Dai DL; Soukhatcheva G; Priatel JJ; Hardenberg G; Levings MK; Tan R; Orban PC; Verchere CB Cell Transplant; 2015; 24(10):2143-54. PubMed ID: 26423995 [TBL] [Abstract][Full Text] [Related]
7. Evidence that intrathymic islet transplantation does not prevent diabetes or subsequent islet graft destruction in RT6-depleted, diabetes-resistant BioBreeding/Worcester rats. Battan R; Mordes JP; Abreau S; Greiner DL; Handler ES; Rossini AA Transplantation; 1994 Mar; 57(5):731-6. PubMed ID: 8140636 [TBL] [Abstract][Full Text] [Related]
8. Cyclosporine therapy concomitant with renal allotransplantation induces tolerance to subsequent donor MHC-identical islet grafts. Ketchum RJ; Su HC; Moyer C; Moore WV Transplant Proc; 1992 Jun; 24(3):899-900. PubMed ID: 1604660 [No Abstract] [Full Text] [Related]
10. Combined transplantation of islets and kidney: immunogenetic analysis in the rat. Hiller WF; Vogt P; Steiniger B; Klempnauer J Transplant Proc; 1993 Feb; 25(1 Pt 2):976-7. PubMed ID: 8442287 [No Abstract] [Full Text] [Related]
11. Incidence of cytomegalovirus infections after immunosuppression induction in clinical islet transplantation and impact on graft function. Eckhard M; Martin I; Eich T; Weimer R; Zinn S; Bretzel RG; Brendel MD Transplant Proc; 2002 Aug; 34(5):1922-4. PubMed ID: 12176630 [No Abstract] [Full Text] [Related]
12. The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade. Makhlouf L; Kishimoto K; Smith RN; Abdi R; Koulmanda M; Winn HJ; Auchincloss H; Sayegh MH Diabetes; 2002 Nov; 51(11):3202-10. PubMed ID: 12401711 [TBL] [Abstract][Full Text] [Related]
13. Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Roep BO; Stobbe I; Duinkerken G; van Rood JJ; Lernmark A; Keymeulen B; Pipeleers D; Claas FH; de Vries RR Diabetes; 1999 Mar; 48(3):484-90. PubMed ID: 10078547 [TBL] [Abstract][Full Text] [Related]
14. Islet transplantation in the twenty-first century. Thomas FT; Hutchings A; Contreras J; Wu J; Jiang XL; Eckhoff D; Thomas JM Immunol Res; 2002; 26(1-3):289-96. PubMed ID: 12403366 [TBL] [Abstract][Full Text] [Related]
15. Human islet allotransplantation under FK 506. Ricordi C; Tzakis A; Carroll P; Zeng Y; Rilo HL; Alejandro R; Shapiro R; Fung JJ; Mintz DH; Starzl TE Transplant Proc; 1991 Dec; 23(6):3207. PubMed ID: 1721410 [No Abstract] [Full Text] [Related]
16. Differences in suppressor of cytokine signaling-1 (SOCS-1) expressing islet allograft destruction in normal BALB/c and spontaneously-diabetic NOD recipient mice. Solomon M; Flodström-Tullberg M; Sarvetnick N Transplantation; 2005 May; 79(9):1104-9. PubMed ID: 15880051 [TBL] [Abstract][Full Text] [Related]
17. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice. Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475 [TBL] [Abstract][Full Text] [Related]
18. Monitoring human islet allografts using a forearm biopsy site. Stegall MD Ann Transplant; 1997; 2(3):8-11. PubMed ID: 9869858 [TBL] [Abstract][Full Text] [Related]